Stockreport

Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions [Yahoo! Finance]

Erasca, Inc.  (ERAS) 
PDF for its pan-RAS degrader ERAS-0015 and continued progress for its pan-KRAS inhibitor ERAS-4001 in Phase 1 trials. This progress underscores Erasca's push to build a di [Read more]